Table 2. Univariate Correlation Between Clinical and Demographic Variables and Geographic Atrophy Growth Rates.
AREDS | FAM/DSGA | GATE | Combined | |||||
---|---|---|---|---|---|---|---|---|
Slope (95% CI) | P Value | Slope (95% CI) | P Value | Slope (95% CI) | P Value | Slope (95% CI)a | P Value | |
Baseline square root geographic atrophy area, per mm | −0.082 (−0.156 to −0.008) | .03 | 0.006 (−0.137 to 0.148) | .93 | 0.001 (−0.114 to 0.115) | .99 | −0.047 (−0.104 to 0.010) | .10 |
Age, per y | −0.003 (−0.023 to 0.017) | .77 | 0.012 (−0.009 to 0.034) | .27 | 0.002 (−0.011 to 0.014) | .75 | −1.574 (−3.660 to 0.512) | .14 |
Female | 0.117 (−0.095 to 0.328) | .28 | 0.062 (−0.266 to 0.389) | .71 | 0.081 (−0.115 to 0.276) | .42 | 0.091 (−0.04 to 0.223) | .19 |
First principal componentb | −4.046 (−8.735 to 0.643) | .09 | −2.225 (−14.46 to 10.01) | .72 | −0.915 (−3.296 to 1.466) | .45 | 0.003 (−0.007 to 0.012) | .54 |
Second principal componentb | 1.749 (−8.165 to 11.66) | .73 | 2.283 (−1.245 to 5.811) | .20 | −0.911 (−5.240 to 3.417) | .68 | 1.062 (−1.566 to 3.690) | .43 |
Geographic atrophy in both eyes | 0.204 (−0.009 to 0.417) | .06 | 0.189 (−0.123 to 0.501) | .24 | 0.281 (0.074 to 0.487) | .008 | 0.233 (0.100 to 0.367) | .001 |
Follow-up time within study period, per y | −0.035 (−0.068 to −0.002) | .04 | −0.070 (−0.133 to −0.006) | .03 | −0.157 (−0.356 to 0.043) | .12 | −0.045 (−0.074 to −0.016) | .002 |
Geographic atrophy lesions, per lesion | 0.277 (0.192 to 0.363) | 6 × 10−10 | 0.161 (0.095 to 0.227) | 3 × 10−06 | 0.134 (0.095 to 0.173) | 6 × 10−11 | 0.159 (0.128 to 0.191) | 2 × 10−23 |
Age-related macular degeneration genetic risk score,c per allele | 0.025 (0.006 to 0.044) | .02 | −0.015 (−0.043 to 0.013) | .21 | 0.016 (−0.003 to 0.034) | .09 | 0.014 (0.002 to 0.027) | .03 |
Abbreviations: AREDS, Age-Related Eye Disease Study; DSGA, Directional Spread in Geographic Atrophy; FAM, Fundus Autofluorescence Imaging in Age-Related Macular Degeneration; GATE, Geographic Atrophy Treatment Evaluation.
Adjusted for study.
Principal components calculated from the genotypes.
Effect size (log odds) weighted age-related macular degeneration genetic risk score calculated from 37 condition-associated, well-imputed variants, normalized by the mean log odds of all 37 variants.8